Alison Ressler Named Dealmaker of the Week by The American Lawyer

February 27, 2015

On February 27, Ms. Ressler was named Dealmaker of the Week by The American Lawyer for advising Valeant Pharmaceuticals in its $14.5 billion acquisition of Salix Pharmaceuticals. Ms. Ressler said, “Valeant looks for terrific products and niche franchises…the GI line is a niche specialty area, and Valeant has been very successful going into niche areas.” The deal will allow Salix to get back on track after recent challenges with inventory issues, which led to a restatement of its earnings for 2013 and most of 2014. Valeant acted quickly to secure the deal, which is expected to close in the second quarter of 2015. Ms. Ressler has advised Valeant on many deals since 2010, including in its $3.2 billion merger with BioVail Corp. and in its unsolicited bid for Allergan.